The Effect of Digital Stories on Nursing Students' Medical Error and Safe Drug Administration

August 22, 2025 updated by: Hakime Aslan, Inonu University

The Effect of Digital Stories on Nursing Students' Medical Error Tendencies and Safe Parenteral Drug Administration Self-Efficacy

Aim This study aimed to determine the effect of digital stories on nursing students' medical error tendencies and safe parenteral drug administration self-efficacy.

Method The study was conducted between May-July 2024 with 64 students (Intervention: 31, Control: 33) studying at the Faculty of Nursing of a university in eastern Turkey and taking the first year nursing principles course. The data were obtained by using 'Personal Information Form', 'Medical Error Tendency Scale, Drug and Transfusion Practices Subscale' and 'Safe Parenteral Drug Administration Self-Efficacy Scale'. During the research process, the students in the experimental group were shared the digital stories prepared for drug applications from the WhatsApp group and were asked to watch them for two weeks.During 2 weeks, the researchers met with the students twice in the classroom environment and received feedback on the digital stories. Students in the control group continued the routine theoretical and practical process.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Digital stories provide personalised learning opportunities that enable students to observe educational environments and events, access them anytime and anywhere, and acquire self-directed learning skills. This method is increasingly being used in education because it offers personalised learning opportunities and enhances teacher-student interaction. In this study, the effects of watching and analysing digital stories prepared for drug administration on nursing students' medical error tendencies and the development of their self-efficacy levels in parenteral drug administration were evaluated.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Malatya
      • Malatya, Malatya, Turkey (Türkiye), 44280
        • Inonu University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being 18 or over
  • To be enrolled in the first year of nursing,
  • To received training on drug administration for the first time,
  • To have no physical disabilities related to vision, hearing and motor skills,
  • To have a smart mobile phone with Android/IOS operating system,
  • To volunteer to participate in the study.

Exclusion Criteria:

  • To repeated the first grade
  • Not volunteering to participate in the research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
No intervention
Experimental: Digital story
The students in the experimental group were shared the digital stories prepared for drug applications from the WhatsApp group and were asked to watch them for two weeks. Students were able to watch the stories on their mobile phones at the time and frequency they wanted. During 2 weeks, the researchers met with the students twice in the classroom environment and received feedback on the digital stories. Feedbacks about the real meaning of the stories and their contribution to education were obtained by using discussion and question-answer methods. Each student explained their opinions about the stories and had the opportunity to think deeply about them by receiving feedback from their classmates.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Efeect of Medical Error Tendency
Time Frame: 2 week

For the pre-test data, 'Individual Introduction Form' and 'Medical Error Tendency Scale' were given to the students and they were asked to fill them in.

At the end of 2 weeks, the 'Medical Error Tendency Scale' was applied again at the end of the 2nd week to see the change in the medical error tendency levels of the students who were trained with digital stories teaching method for 2 weeks. Medical Error Tendency Scale: It was developed by Özata and Altunkan to measure the medical error tendencies of nurses. The scale consists of 49 items and 5 different sub-dimensions, and the sub-dimension used in this study, the sub-dimension of medication and transfusion practices, consists of 18 items. The higher the mean score of the scale, the lower the tendency of nurses to make medical errors.

2 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of Safe Parenteral Drug Administration Self-Efficacy
Time Frame: 2 weeks
Safe Parenteral Drug Administration Self-Efficacy Scale: The scale developed to determine the self-efficacy of nurses regarding parenteral drug administration consists of 76 items and one dimension. The scale is a 5-point Likert-type scale and 1: Completely disagree, 2: Disagree, 3: Undecided, 4: Agree, 5: Strongly agree. A minimum score of 76 and a maximum score of 380 can be obtained from the scale. The higher the score obtained from the scale, the higher the self-efficacy of nurses regarding safe parenteral drug administration.
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hakime Aslan, Faculty of Nursing

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2024

Primary Completion (Actual)

July 15, 2024

Study Completion (Actual)

August 15, 2025

Study Registration Dates

First Submitted

August 17, 2025

First Submitted That Met QC Criteria

August 22, 2025

First Posted (Estimated)

August 26, 2025

Study Record Updates

Last Update Posted (Estimated)

August 26, 2025

Last Update Submitted That Met QC Criteria

August 22, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HakimeAslan

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nursing Students

Clinical Trials on Intervention

Subscribe